Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.

Wasle, I, Gamerith, G, Kocher, F, Mondello, P, Jaeger, T, Walder, A, Auberger, J, Melchardt, T, Linkesch, W, Fiegl, M, Mian, M.

http://www.ncbi.nlm.nih.gov/pubmed/25387663